UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 262

Sortiert nach

Praxis der Therapie des Typ-II-Diabetes: Pathophysiologische Grundlagen, Metabolisches Syndrom, Differentialtherapie, Komplikationen

Hanefeld, Markolf

2020

Link zum Volltext

Verfügbarkeit prüfen

The Current and Potential Therapeutic Use of Metformin-The Good Old Drug

Pharmaceuticals (Basel, Switzerland), 2021-02, Vol.14 (2), p.122

2021

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes

Cardiovascular diabetology, 2007-08, Vol.6 (1), p.20-20

Hanefeld, Markolf

2007

Link zum Volltext

Verfügbarkeit prüfen

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

The Lancet (British edition), 2009-06, Vol.373 (9681), p.2125-2135

2009

Link zum Volltext

Verfügbarkeit prüfen

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

Diabetes care, 2016-08, Vol.39 (8), p.1318-1328

2016

Link zum Volltext

Verfügbarkeit prüfen

Praxis der Therapie des Typ-II-Diabetes: Pathophysiologische Grundlagen, Metabolisches Syndrom, Differentialtherapie, Komplikationen

Markolf Hanefeld / Markolf Hanefeld

2020

Link zum Volltext

Verfügbarkeit prüfen

Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update

Diabetes therapy, 2020-08, Vol.11 (8), p.1645-1666

2020

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers

Diabetologia, 2021-12, Vol.64 (12), p.2701-2712

2021

Link zum Volltext

Verfügbarkeit prüfen

A Practical Guide to the Therapy of Type-II-Diabetes

Markolf Hanefeld / Markolf Hanefeld

2014

Link zum Volltext

Verfügbarkeit prüfen

The metabolic vascular syndrome - guide to an individualized treatment

Reviews in Endocrine & Metabolic Disorders, 2016-03, Vol.17 (1), p.5-17

2016

Link zum Volltext

Verfügbarkeit prüfen

The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL

Cardiovascular diabetology, 2017-05, Vol.16 (1), p.66-9, Article 66

2017

Link zum Volltext

Verfügbarkeit prüfen

Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes

PloS one, 2017-10, Vol.12 (10), p.e0184234-e0184234

2017

Link zum Volltext

Verfügbarkeit prüfen

Sudomotor Testing of Diabetes Polyneuropathy

Frontiers in neurology, 2018-09, Vol.9, p.803-803

2018

Link zum Volltext

Verfügbarkeit prüfen

In Type 2 Diabetes, Rosiglitazone Therapy for Insulin Resistance Ameliorates Endothelial Dysfunction Independent of Glucose Control

Diabetes care, 2004-02, Vol.27 (2), p.484-490

2004

Link zum Volltext

Verfügbarkeit prüfen

Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for “late-onset” hypogonadism: A case report

SAGE open medical case reports, 2019-01, Vol.7, p.2050313X18823454

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a Diabetes Management System Based on Practice Guidelines, Integrated Care, and Continuous Quality Management in a Federal State of Germany

Diabetes care, 2008-05, Vol.31 (5), p.863-868

2008

Link zum Volltext

Verfügbarkeit prüfen

One-Year Glycemic Control With a Sulfonylurea Plus Pioglitazone Versus a Sulfonylurea Plus Metformin in Patients With Type 2 Diabetes

Diabetes care, 2004-01, Vol.27 (1), p.141-147

2004

Link zum Volltext

Verfügbarkeit prüfen

Postprandial hyperglycaemia and cardiovascular complications of diabetes: An update

Nutrition, metabolism, and cardiovascular diseases, 2006-10, Vol.16 (7), p.453-456

2006

Link zum Volltext

Verfügbarkeit prüfen

Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study

Cardiovascular diabetology, 2011-07, Vol.10 (1), p.65-65

2011

Link zum Volltext

Verfügbarkeit prüfen

Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study

Cardiovascular diabetology, 2007-04, Vol.6 (1), p.13-13

2007

Link zum Volltext

Verfügbarkeit prüfen

Hypoglycemia and Cardiovascular Risk: Is There a Major Link?

Diabetes care, 2016-08, Vol.39 Suppl 2 (Supplement_2), p.S205-S209

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol

Diabetes therapy, 2019-02, Vol.10 (1), p.329-331

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes

Cardiovascular diabetology, 2013-04, Vol.12 (1), p.62-62

2013

Link zum Volltext

Verfügbarkeit prüfen

Hypoadiponectinemia Is Associated With Progression Toward Type 2 Diabetes and Genetic Variation in the ADIPOQ Gene Promoter

Diabetes care, 2006-07, Vol.29 (7), p.1645-1650

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(234)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(125)
Science & Technology
(117)
Life Sciences & Biomedicine
(115)
Male
(81)
Female
(77)
Endocrinology & Metabolism
(76)
Middle Aged
(75)
Diabetes
(65)
Aged
(58)
Risk Factors
(51)
Adult
(48)
Diabetes Mellitus, Type 2 - Drug Therapy
(48)
Medical Sciences
(48)
Biological And Medical Sciences
(46)
Hypoglycemic Agents - Therapeutic Use
(46)
Type 2 Diabetes
(46)
Endocrinology
(35)
Diabetes Mellitus, Type 2 - Blood
(31)
Cardiovascular System & Cardiology
(27)
Endocrinopathies
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Praxis der Therapie des Typ-II-Diabetes: Pathophysiologische Grundlagen, Metabolisches Syndrom, Differentialtherapie, Komplikationen

The Current and Potential Therapeutic Use of Metformin-The Good Old Drug

Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial

Praxis der Therapie des Typ-II-Diabetes: Pathophysiologische Grundlagen, Metabolisches Syndrom, Differentialtherapie, Komplikationen

Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update

Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers

A Practical Guide to the Therapy of Type-II-Diabetes

The metabolic vascular syndrome - guide to an individualized treatment

The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL

Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes

Sudomotor Testing of Diabetes Polyneuropathy

In Type 2 Diabetes, Rosiglitazone Therapy for Insulin Resistance Ameliorates Endothelial Dysfunction Independent of Glucose Control

Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies

Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for “late-onset” hypogonadism: A case report

Evaluation of a Diabetes Management System Based on Practice Guidelines, Integrated Care, and Continuous Quality Management in a Federal State of Germany

One-Year Glycemic Control With a Sulfonylurea Plus Pioglitazone Versus a Sulfonylurea Plus Metformin in Patients With Type 2 Diabetes

Postprandial hyperglycaemia and cardiovascular complications of diabetes: An update

Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study

Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study

Hypoglycemia and Cardiovascular Risk: Is There a Major Link?

Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes

Hypoadiponectinemia Is Associated With Progression Toward Type 2 Diabetes and Genetic Variation in the ADIPOQ Gene Promoter

Suchergebnisse filtern